Skip to main content
MICRO-X LIMITED logo

MICRO-X LIMITED — Investor Relations & Filings

Ticker · MX1 ISIN · AU000000MX15 ASX Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2020-05-31 Capital/Financing Update
Country AU Australia
Listing ASX MX1

About MICRO-X LIMITED

https://www.micro-x.com

Micro-X Limited specializes in the development and commercialization of innovative X-ray products utilizing proprietary carbon nanotube (CNT) cold cathode technology. This technology enables the miniaturization of X-ray sources, allowing for the creation of lightweight, portable, and highly efficient imaging systems. The company's product portfolio includes the Nano and Rover mobile medical X-ray units designed for bedside and field hospital use, and the Argus X-ray camera for high-resolution security and counter-IED applications. Micro-X is also developing advanced solutions for airport security through self-service checkpoints and portable head CT scanners for rapid stroke diagnosis in pre-hospital environments. By replacing traditional, bulky thermionic X-ray tubes with electronic CNT emitters, the company provides enhanced mobility and digital precision across medical, defense, and security markets.

Recent filings

Filing Released Lang Actions
Market update - Micro-X Rover Testing Complete 2 pages 250.9KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated June 1, 2020, from Micro-X Limited providing a market update on the completion of compliance tests for their Rover mobile X-ray product and plans for FDA 510(k) submission. It discusses product development progress, regulatory submission plans, and commercialisation efforts. There are no financial statements, detailed financial data, or comprehensive report content. The document is a corporate announcement about product and regulatory progress rather than a financial report or detailed investor presentation. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is not a regulatory filing about compliance or officer certification either. The content is best classified as a Capital/Financing Update (CAP) because it mentions the use of funds from a recent $15 million Placement and Entitlement Offer to advance product development, which relates to financing activities and capital use. Therefore, the most appropriate classification is CAP with high confidence.
2020-05-31 English
Micro - X - Nano shipment and reduction in backlog 2 pages 248.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Micro-X Limited providing an update on the shipment and order backlog reduction of their product, the Carestream DRX Revolution Nano. It includes operational and market update details such as shipment values, backlog reduction, delivery times, and investment in production capacity. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is relatively short (4642 characters) and serves as a market update or operational progress announcement rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is also not a report publication announcement or certification. The content is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement providing material operational information to the market without fitting into more specific categories.
2020-05-28 English
Resignation of Company Secretary 1 page 181.5KB
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a Co-Company Secretary and appointment of a new sole Company Secretary. It contains no financial data, no report or presentation, and no regulatory filings beyond this management change. The content clearly relates to a change in senior management personnel. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2020-05-28 English
Ceasing to be a substantial holder 2 pages 38.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 filed under the Corporations Act 2001, titled 'Notice of ceasing to be a substantial holder.' It details changes in relevant interests of a substantial shareholder, Carestream Health Inc., including dates and shareholding percentages falling below 5%. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not a financial report, earnings release, or management report, but a regulatory notification about shareholding changes.
2020-05-21 English
Change of Director's Interest Notice 2 pages 175.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in shareholding, including the number of shares acquired and the nature of the transaction. There is no financial performance data, earnings information, or management discussion. The content is focused on reporting a director's personal share transactions. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3431 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS.
2020-05-14 English
Change of Director's Interest Notice 2 pages 183.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of shares acquired and the nature of the interest. There is no financial performance data, earnings information, or management discussion. The content strictly relates to insider share transactions by a director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3553 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS with high confidence.
2020-05-14 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.